June 19 (NBD)-- Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) announced last Saturday that its board of directors had approved the incentive plan to grant 2.1632 million restricted shares to 209 qualified recipients at the price of 7.7 yuan (1.2 U.S. dollars) per share.

The shares awarded would be common stock repurchased from the secondary market, according to the announcement.

Email: tanyuhan@nbd.com.cn